SP1 acts as a key factor, contributes to upregulation of ADAM23 expression under serum deprivation

Biochemical and Biophysical Research Communications

Volumn 401, Issue 2, 2010, Pages 306-312

  Pan, Qiuhui ^a   Yang, Songhai ^b   Wei, Youzhen ^c   Sun, Fenyong ^a   Li, Zhi ^a  

^a TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

^b Zhongcun Hospital   (China)

^c Chinese Academy of Sciences   (China)

Author keywords

Epigenetic modification; Gene regulation; Promoter; Starvation; Transcription factor

Indexed keywords

ADAM PROTEIN; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; PROTEIN ADAM23; RNA POLYMERASE II; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; HUMAN; MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION;

ADAM PROTEINS; BINDING SITES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; RNA POLYMERASE II; SERUM; SP1 TRANSCRIPTION FACTOR; UP-REGULATION;

EID: 77957799577     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.058     Document Type: Article

References (23)

1. Goldsmith A.P., Gossage S.J., ffrench-Constant C. ADAM23 is a cell-surface glycoprotein expressed by central nervous system neurons. J. Neurosci. Res. 2004, 78:647-658.
2. Choi J.S., Kim K.H., Jeon Y.K., Kim S.H., Jang S.G., Ku J.L., Park J.G. Promoter hypermethylation of the ADAM23 gene in colorectal cancer cell lines and cancer tissues. Int. J. Cancer 2009, 124:1258-1262.
3. Tsuda H., Nakanishi Y., Ichikura T., Mochizuki H., Mitsufuji S., Hosoda F., Hirohashi S., Ohki M., Inazawa J. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation. Oncogene 2005, 24:8051-8060.
4. Verbisck N.V., Costa É.T., Costa F.F., Cavalher F.P., Costa M.D.M., Muras A., et al. ADAM23 negatively modulates αvβ3 integrin activation during metastasis. Cancer Res. 2009, 69:5546-5552.
5. Costa1 F.F., Verbisck N.V., Salim A.C.M., Ierardi D.F., Pires L.C., Sasahara R.M., et al. Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene 2004, 23:1481-1488.
6. J.Y. Wang, X.F. Liu, H.C. Wu, P.F. Ni, Z.D. Gu, Y.X. Qiao, N. Chen, F.Y. Sun, Q.S. Fan, CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer, Nucleic Acids Res. (2010) Advance Published. doi: 10.1093/nar/gkq285.
7. Sun F.Y., Chen Q.Y., Yang S.H., Pan Q.H., Ma J., Wan Y., Chang C.H., Hong A. Remodeling of chromatin structure within the promoter is important for bmp-2-induced fgfr3 expression. Nucleic Acids Res. 2009, 37:3897-3911.
8. Wang J.Y., Liu X.F., Ni P.F., Gu Z.D., Fan Q.S. SP1 is required for basal activation and chromatin accessibility of CD151 promoter in liver cancer cells. Biochem. Biophys. Res. Commun. 2010, 393:291-296.
9. Wang J.Y., Qiao Y.X., Sun F.Y., Wan Y., Huang T., Ye T.J., Yu Y.C. Identification and characterization of mouse Gas6 promoter. Biochem. Biophys. Res. Commun. 2008, 371:567-572.
10. Rao S., Procko E., Shannon M.F. Chromatin remodeling, measured by a novel real-time polymerase chain reaction assay, across the proximal promoter region of the IL-2 Gene. J. Immunol. 2001, 167:4494-4503.
11. Sun F.Y., Wang J.Y., Pan Q.H., Yu Y.C., Zhang Y., Wan Y., Wang J., Li X.Y., Hong A. Characterization of function and regulation of miR-24-1 and miR-31. Biochem. Biophys. Res. Commun. 2009, 380:660-665.
12. Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr. Opin. Cell Biol. 2008, 20:341-348.
13. Vakoc C., Mandat S., Olenchock B., Blobel G. Histone H3 lysine 9 methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Mol. Cell 2005, 19:381-391.
14. Courey A.J., Tjian R. Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif. Cell 1988, 55:887-898.
15. Jackson S.P., MacDonald J.J., Lees-Miller S., Tjian R. GC boxbinding induces phosphorylation of Sp1 by a DNA-dependent protein kinase. Cell 1990, 63:155-165.
16. Han I., Kudlow J.E. Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility. Mol. Cell. Biol. 1997, 17:2550-2558.
17. Roos M.D., Su K., Baker J.R., Kudlow J.E. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions. Mol. Cell. Biol. 1997, 17:6472-6480.
18. Gill G., Pascal E., Tseng Z.H., Tjian R. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation. Proc. Natl. Acad. Sci. USA 1994, 91:192-196.
19. Pugh B.F., Tjian R. Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell 1990, 61:1187-1197.
20. Ryu S., Zhou S., Ladurner A.G., Tijan R. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature 1999, 397:446-450.
21. Kim S.J., Onwuta U.S., Lee Y.I., Li R., Botchan M.R., Robbins P.D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 1992, 12:2455-2463.
22. Hoey T., Weinzierl R.O., Gill G., Chen J.L., Dynlacht B.D., Tjian R. Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 1993, 72:247-260.
23. Saluja D., Vassallo M.F., Tanese N. Distinct subdomains of human TAFII130 are required for interactions with glutamine-rich transcriptional activators. Mol. Cell. Biol. 1998, 18:5734-5743.